Goldman Sachs’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-265,344
| Closed | -$18M | – | 5548 |
|
|
2019
Q3 | $18M | Sell |
265,344
-425,638
| -62% | -$29.2M | 0.01% | 1867 |
|
|
2019
Q2 | $40.2M | Sell |
690,982
-87,817
| -11% | -$5.2M | 0.01% | 1302 |
|
|
2019
Q1 | $54.6M | Buy |
778,799
+120,763
| +18% | +$8.95M | 0.02% | 1041 |
|
|
2018
Q4 | $42.4M | Sell |
658,036
-11,738
| -2% | -$823K | 0.01% | 1213 |
|
|
2018
Q3 | $47M | Buy |
669,774
+54,572
| +9% | +$3.19M | 0.01% | 1266 |
|
|
2018
Q2 | $31M | Buy |
615,202
+193,197
| +46% | +$7.67M | 0.01% | 1574 |
|
|
2018
Q1 | $13.2M | Buy |
422,005
+17,762
| +4% | +$589K | ﹤0.01% | 2129 |
|
|
2017
Q4 | $13.8M | Sell |
404,243
-45,513
| -10% | -$1.45M | ﹤0.01% | 2208 |
|
|
2017
Q3 | $14.4M | Buy |
449,756
+78,950
| +21% | +$2.49M | ﹤0.01% | 2261 |
|
|
2017
Q2 | $12.1M | Buy |
370,806
+76,758
| +26% | +$2.43M | ﹤0.01% | 2356 |
|
|
2017
Q1 | $9.26M | Buy |
294,048
+81,425
| +38% | +$2.41M | ﹤0.01% | 2471 |
|
|
2016
Q4 | $6.25M | Buy |
212,623
+41,405
| +24% | +$1.26M | ﹤0.01% | 2858 |
|
|
2016
Q3 | $4.95M | Buy |
171,218
+59,161
| +53% | +$1.65M | ﹤0.01% | 3053 |
|
|
2016
Q2 | $2.9M | Buy |
112,057
+30,191
| +37% | +$802K | ﹤0.01% | 3300 |
|
|
2016
Q1 | $2.03M | Buy |
81,866
+51,635
| +171% | +$1.42M | ﹤0.01% | 3455 |
|
|
2015
Q4 | $1.06M | Sell |
30,231
-83,525
| -73% | -$2.24M | ﹤0.01% | 4232 |
|
|
2015
Q3 | $2.41M | Sell |
113,756
-155,933
| -58% | -$4.02M | ﹤0.01% | 3612 |
|
|
2015
Q2 | $7.49M | Buy |
269,689
+165,155
| +158% | +$4.66M | ﹤0.01% | 2584 |
|
|
2015
Q1 | $3.19M | Sell |
104,534
-41,586
| -28% | -$1.32M | ﹤0.01% | 3331 |
|
|
2014
Q4 | $4.67M | Buy |
146,120
+5,055
| +4% | +$165K | ﹤0.01% | 3060 |
|
|
2014
Q3 | $3.99M | Buy |
141,065
+69,724
| +98% | +$1.94M | ﹤0.01% | 3237 |
|
|
2014
Q2 | $1.95M | Buy |
71,341
+2,361
| +3% | +$62.8K | ﹤0.01% | 4017 |
|
|
2014
Q1 | $1.82M | Sell |
68,980
-104,537
| -60% | -$3M | ﹤0.01% | 4068 |
|
|
2013
Q4 | $5.08M | Sell |
173,517
-13,109
| -7% | -$416K | ﹤0.01% | 3067 |
|
|
2013
Q3 | $5.71M | Sell |
186,626
-14,788
| -7% | -$495K | ﹤0.01% | 2800 |
|
|
2013
Q2 | $6.39M | Buy |
+201,414
| New | +$6.62M | ﹤0.01% | 2501 |
|
Goldman Sachs's GHDX Position: Q4 2019 in Review
Goldman Sachs sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 265,344 shares — an estimated $18M sold.
Goldman Sachs first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $54.6M in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Goldman Sachs reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Goldman Sachs sold 265,344 Genomic Health, Inc. shares in Q4 2019, an estimated $18M.
- Goldman Sachs first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
- Goldman Sachs's Genomic Health, Inc. position peaked at $54.6M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Goldman Sachs's 13F filing for Q4 2019, filed 14 Feb 2020.